Keshen A

Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.

5 papers · 1 preprint · ORCID

ArticlePsilocybin

Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.

Koning E, Richard J, Keshen A

Europe PMC2026
ArticlePsilocybin

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development.

Koning E, Gamberg S, Keshen A

Europe PMC2026
PreprintPsilocybin

Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development

Koning E, Gamberg S, Keshen A

Europe PMC2025
ArticlePsilocybin

Innovative Pharmacological Approaches to Eating Disorder Treatment.

Keshen A, Touyz S, Lacroix E +2

Europe PMC2026
ArticlePsychedelics

Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective.

Koning E, McMillan RM, Keshen A +4

Europe PMC2025
ArticlePsychedelics

Psychedelics and the treatment of eating disorders: considerations for future research and practice.

Lacroix E, Fatur K, Hay P +2

Europe PMC2024